<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    AVROBIO, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About AVROBIO, Inc.

    AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical stage company developing disruptive therapies that have the potential to transform patients’ lives in a single dose. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $440,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Geoff MacKay
    • FOUNDED
      2015
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    ImmunoGen, Inc.

    ImmunoGen, Inc.

    ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to ...

    ImmunoGen is developing the next generation of ...

    Filing Type:    PU
    Bio-Path Holdings, Inc.

    Bio-Path Holdings, Inc.

    Bio-Path is a biotechnology company developing targeted therapies for acute myeloi...

    Bio-Path is a biotechnology company developing ...

    Filing Type:    PU
    Dyadic International, Inc.

    Dyadic International, Inc.

    Dyadic International, Inc. is a global biotechnology company based in Jupiter, Flo...

    Dyadic International, Inc. is a global biotechn...

    Filing Type:    PU
    Jounce Therapeutics, Inc.

    Jounce Therapeutics, Inc.

    Jounce Therapeutics is a clinical stage immunotherapy company dedicated to transfo...

    Jounce Therapeutics is a clinical stage immunot...

    Filing Type:    PU
    Bio-Techne Corp

    Bio-Techne Corp

    Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of h...

    Bio-Techne Corporation (NASDAQ: TECH) is a lead...

    Filing Type:    PU
    NeoGenomics, Inc.

    NeoGenomics, Inc.

    NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory and phar...

    NeoGenomics, Inc. is a high-complexity CLIA-cer...

    Filing Type:    PU
    bluebird bio, Inc.

    bluebird bio, Inc.

    bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., h...

    bluebird bio is pioneering gene therapy with pu...

    Filing Type:    PU
    MeiraGTx Holdings plc

    MeiraGTx Holdings plc

    We are a vertically integrated, clinical stage gene therapy company with four ongo...

    We are a vertically integrated, clinical stage ...

    Filing Type:    PU
    Mustang Bio, Inc.

    Mustang Bio, Inc.

    Mustang Bio, Inc. (“Mustang”), a Fortress Biotech Company, is a clinical-stage...

    Mustang Bio, Inc. (“Mustang”), a Fortress B...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.